Luisa Seguella Selected Research

Luisa Seguella Research Topics

Disease

15	Inflammation (Inflammations) 03/2024 - 01/2016
6	Colitis 12/2023 - 01/2016
5	COVID-19 01/2023 - 11/2020
4	Infections 03/2024 - 05/2021
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 08/2016
3	Ulcerative Colitis 12/2023 - 01/2020
3	Hypoxia (Hypoxemia) 01/2021 - 07/2019
3	Neoplasms (Cancer) 01/2020 - 07/2019
2	Pain (Aches) 01/2022 - 11/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2021 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2020 - 06/2016
2	Diarrhea 03/2018 - 10/2017
1	Lung Injury 03/2024
1	Ileus 10/2023
1	Weight Loss (Weight Reduction) 07/2022
1	Morbid Obesity 07/2022
1	Severe Acute Respiratory Syndrome 12/2021
1	Hyperalgesia 11/2021
1	Visceral Pain 11/2021
1	Body Weight (Weight, Body) 05/2021
1	Communicable Diseases (Infectious Diseases) 05/2021
1	Hypersensitivity (Allergy) 01/2021
1	Dyspepsia (Indigestion) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2020
1	Acute Lung Injury 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2019
1	Neuroinflammatory Diseases 03/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Clostridium Infections 01/2016
1	Herpes Zoster 01/2016
1	Hemorrhage 01/2016

Drug/Important Bio-Agent (IBA)

8	palmidrolIBA 09/2021 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2017
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2016
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2016
5	NF-kappa B (NF-kB)IBA 01/2021 - 01/2016
3	VaccinesIBA 03/2024 - 11/2020
3	2,4-dinitrofluorobenzene sulfonic acidIBA 12/2023 - 11/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2020
2	Tight Junction ProteinsIBA 01/2022 - 01/2021
2	CannabidiolIBA 12/2021 - 11/2020
2	LipidsIBA 09/2021 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 07/2019
2	Clostridium difficile tcdA proteinIBA 01/2021 - 01/2016
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2021 - 01/2016
2	EnzymesIBA 01/2021 - 01/2018
2	PPAR alphaIBA 03/2018 - 01/2016
1	Hyaluronic Acid (Hyaluronan)IBA 12/2023
1	adelmidrolIBA 12/2023
1	Cholinergic Agents (Cholinergics)IBA 10/2023
1	BQ 788IBA 10/2023
1	GliotoxinIBA 10/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2023
1	Glucosamine (Dona)IBA 01/2022
1	Prostaglandins AIBA 01/2022
1	Caspase 1 (ICE Protease)IBA 12/2021
1	Angiotensin-Converting Enzyme 2IBA 12/2021
1	PoisonsIBA 11/2021
1	fluorocitrateIBA 11/2021
1	ElementsIBA 11/2021
1	dinitrobenzenesulfonic acidIBA 11/2021
1	OccludinIBA 05/2021
1	PalmitatesIBA 03/2021
1	AmidesIBA 03/2021
1	AutacoidsIBA 03/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	AcidsIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Phospholipase DIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	phosphatidylethanolamineIBA 01/2021
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 11/2020
1	CytokinesIBA 11/2020
1	Pentamidine (NebuPent)FDA LinkGeneric 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	Receptor for Advanced Glycation End ProductsIBA 07/2019
1	Amine Oxidase (Copper-Containing)IBA 07/2019
1	AldehydesIBA 07/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2019
1	Trans-Activators (Trans-Acting Factor)IBA 03/2018
1	AntidiarrhealsIBA 03/2018
1	tat Gene Products (tat Protein)IBA 03/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2016
1	Rifaximin (L 105)FDA Link 08/2016
1	Pregnane X ReceptorIBA 08/2016
1	Toll-Like Receptor 4IBA 01/2016
1	Myeloid Differentiation Factor 88IBA 01/2016
1	Dextrans (Dextran)FDA Link 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016

Therapy/Procedure

3	Therapeutics 06/2019 - 10/2017
1	Intranasal Administration 03/2024
1	Enema (Enemas) 12/2023
1	Gastrectomy 07/2022
1	Chemoprevention 08/2016